SN
Shankarappa Nagaraja Vinaya Babu
About Shankarappa Nagaraja Vinaya Babu
Data last updated:
Shankarappa Nagaraja Vinaya Babu has 19 years in corporate governance. Holds Director and Managing Director roles. Currently with 8 companies, including Pharmaids Pharmaceuticals Limited and Bioneeds India Private Limited. Formerly with 9 companies, such as Southfine Foods Private Limited and Celest Pharma Labs Private Limited. Engaged in General Business. Contributes to corporate operations. The 6 current companies with reported revenue have a combined latest revenue of ₹746 Cr; the largest is Veeda Clinical Research Limited at ₹621 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jul 2021 | 2004 | ₹621 Cr (FY 2025) | Active | |
| Managing Director | 28 Mar 2007 | 2007 | ₹116 Cr (FY 2024) | Active | |
| Director | 23 May 2018 | 2018 | ₹4.70 Cr (FY 2024) | Active | |
| Director | 31 Jan 2024 | 1989 | ₹3.95 Cr (FY 2022) | Active | |
| Non- Individual Subscriber | 17 May 2023 | 2023 | ₹14.1 Lakh (FY 2025) | Active | |
| Director | 03 Jul 2017 | 2017 | ₹18,360 (FY 2025) | Active | |
| Director | 18 Jul 2017 | 2017 | – | Active | |
| Director | 16 May 2012 | 2012 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Aug 2016 | 2016 | ₹65.6 Lakh (FY 2023) | Active | |
| Director | 17 Mar 2010 | 2010 | ₹11.91 Cr (FY 2025) | Active | |
| Director | 18 Apr 2025 | 2022 | ₹18.55 Cr (FY 2025) | Active | |
| Director | 13 Jul 2017 | 2017 | – | Active | |
| Director | 07 Aug 2020 | 2020 | – | Active | |
| Director | 17 Mar 2016 | 2016 | – | Active | |
| Director | 06 Jul 2017 | 2017 | – | Strike Off | |
| Director | 29 Jul 2020 | 2020 | – | Strike Off | |
| Director | 18 Sep 2018 | 2018 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shankarappa Nagaraja Vinaya Babu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shankarappa Nagaraja Vinaya Babu
Shankarappa Nagaraja Vinaya Babu has 19 years in corporate governance. Holds Director and Managing Director roles. Currently with 8 companies, including Pharmaids Pharmaceuticals Limited and Bioneeds India Private Limited. Formerly with 9 companies, such as Southfine Foods Private Limited and Celest Pharma Labs Private Limited. Engaged in General Business. Contributes to corporate operations. The 6 current companies with reported revenue have a combined latest revenue of ₹746 Cr; the largest is Veeda Clinical Research Limited at ₹621 Cr (FY 2025).
Shankarappa Nagaraja Vinaya Babu is associated with 8 companies as Director and Managing Director, including Veeda Clinical Research Limited (₹621 Cr), Bioneeds India Private Limited (₹116 Cr), Tumkur Trade Center Private Limited (₹4.70 Cr).
Shankarappa Nagaraja Vinaya Babu has expertise in General Business.
Shankarappa Nagaraja Vinaya Babu has 19 years in corporate governance.
By reported revenue, the largest current company of Shankarappa Nagaraja Vinaya Babu is Veeda Clinical Research Limited, with revenue of ₹621 Cr (FY 2025).
The 6 current companies of Shankarappa Nagaraja Vinaya Babu that report revenue have a combined latest revenue of ₹746 Cr.
Shankarappa Nagaraja Vinaya Babu currently holds positions at 8 companies; the 5 largest by reported revenue are Veeda Clinical Research Limited (₹621 Cr), Bioneeds India Private Limited (₹116 Cr), Tumkur Trade Center Private Limited (₹4.70 Cr), Pharmaids Pharmaceuticals Limited (₹3.95 Cr), Siri Labvivo Diet Private Limited (₹14.1 Lakh).